Literature DB >> 19889714

Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease.

Michel Grothe1, Laszlo Zaborszky, Mercedes Atienza, Eulogio Gil-Neciga, Rafael Rodriguez-Romero, Stefan J Teipel, Katrin Amunts, Aida Suarez-Gonzalez, Jose L Cantero.   

Abstract

Neuropathological studies suggest that the basal forebrain cholinergic system (BFCS) is affected in Alzheimer's disease (AD), but there is no in vivo evidence of early damage to this system in subjects at high risk of developing AD. Here, we found that mild cognitive impairment (MCI) patients exhibited significant volume reduction of the nucleus basalis of Meynert (NbM) using recently developed probabilistic maps of the BFCS space. In addition, volumes of different magnocellular compartments varied significantly with regional gray matter atrophy in regions known to be affected by AD and were found to correlate with cognitive decline in MCI patients. Bilateral reductions of the horizontal nucleus of the diagonal band of Broca (Ch3) and frontal lobe (medial frontal, orbital, subcallosal gyrus, anterior cingulate, and middle frontal gyrus) were significantly associated with a global decline in cognitive status, whereas volume reduction of the posterior compartment of Ch4 (NbM) and temporal lobe (including hippocampus, entorhinal cortex, and amygdala) were associated with impaired delayed recall in MCI patients. These findings establish, for the first time, a link between degeneration of specific cholinergic compartments of the BFCS and cognitive-related deficits in subjects at high risk of developing AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889714      PMCID: PMC2912653          DOI: 10.1093/cercor/bhp232

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  58 in total

1.  Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients.

Authors:  B A Pappas; P J Bayley; B K Bui; L A Hansen; L J Thal
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  "Voxel-based morphometry" should not be used with imperfectly registered images.

Authors:  F L Bookstein
Journal:  Neuroimage       Date:  2001-12       Impact factor: 6.556

3.  Mild cognitive impairment and the cholinergic hypothesis: a very different take on recent data.

Authors:  Martin Sarter; John P Bruno
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

4.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.

Authors:  Haruo Hanyu; Tetsuichi Asano; Hirofumi Sakurai; Yuriko Tanaka; Masaru Takasaki; Kimihiko Abe
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

5.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

6.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

7.  Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.

Authors:  Stefan J Teipel; Christine Born; Michael Ewers; Arun L W Bokde; Maximilian F Reiser; Hans-Jürgen Möller; Harald Hampel
Journal:  Neuroimage       Date:  2007-07-18       Impact factor: 6.556

8.  Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer's disease patients.

Authors:  Yuriko Tanaka; Haruo Hanyu; Hirofumi Sakurai; Masaru Takasaki; Kimihiko Abe
Journal:  Dement Geriatr Cogn Disord       Date:  2003       Impact factor: 2.959

9.  Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment.

Authors:  Gaël Chételat; Béatrice Desgranges; Vincent De La Sayette; Fausto Viader; Francis Eustache; Jean-Claude Baron
Journal:  Neuroreport       Date:  2002-10-28       Impact factor: 1.837

Review 10.  Mild cognitive impairment.

Authors:  Howard Chertkow
Journal:  Curr Opin Neurol       Date:  2002-08       Impact factor: 5.710

View more
  67 in total

1.  Polysomnographic and subjective sleep markers of mild cognitive impairment.

Authors:  Eva Hita-Yañez; Mercedes Atienza; Jose L Cantero
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

2.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

Authors:  Stefan Teipel; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Bernd Krause; Michel Grothe
Journal:  Neurobiol Aging       Date:  2013-10-28       Impact factor: 4.673

3.  Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan J Teipel
Journal:  Biol Psychiatry       Date:  2011-08-04       Impact factor: 13.382

Review 4.  Staging Alzheimer's disease progression with multimodality neuroimaging.

Authors:  Michael Ewers; Giovanni B Frisoni; Stefan J Teipel; Lea T Grinberg; Edson Amaro; Helmut Heinsen; Paul M Thompson; Harald Hampel
Journal:  Prog Neurobiol       Date:  2011-06-22       Impact factor: 11.685

5.  Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.

Authors:  Michel J Grothe; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Stefan J Teipel
Journal:  Cereb Cortex       Date:  2015-04-02       Impact factor: 5.357

6.  Developmental suppression of forebrain trkA receptors and attentional capacities in aging rats: A longitudinal study.

Authors:  Brittney Yegla; Vinay Parikh
Journal:  Behav Brain Res       Date:  2017-08-10       Impact factor: 3.332

7.  Functional Subdivisions of Magnocellular Cell Groups in Human Basal Forebrain: Test-Retest Resting-State Study at Ultra-high Field, and Meta-analysis.

Authors:  Rui Yuan; Bharat B Biswal; Laszlo Zaborszky
Journal:  Cereb Cortex       Date:  2019-07-05       Impact factor: 5.357

8.  The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study.

Authors:  Stefan J Teipel; Thomas Meindl; Lea Grinberg; Michel Grothe; Jose L Cantero; Maximilian F Reiser; Hans-Jürgen Möller; Helmut Heinsen; Harald Hampel
Journal:  Hum Brain Mapp       Date:  2010-07-29       Impact factor: 5.038

9.  Trail Making Test Elucidates Neural Substrates of Specific Poststroke Executive Dysfunctions.

Authors:  Ryan T Muir; Benjamin Lam; Kie Honjo; Robin D Harry; Alicia A McNeely; Fu-Qiang Gao; Joel Ramirez; Christopher J M Scott; Anoop Ganda; Jiali Zhao; X Joe Zhou; Simon J Graham; Novena Rangwala; Erin Gibson; Nancy J Lobaugh; Alex Kiss; Donald T Stuss; David L Nyenhuis; Byung-Chul Lee; Yeonwook Kang; Sandra E Black
Journal:  Stroke       Date:  2015-09-17       Impact factor: 7.914

10.  Alleviating effects of Bushen-Yizhi formula on ibotenic acid-induced cholinergic impairments in rat.

Authors:  Xue-Qin Hou; Lei Zhang; Cong Yang; Cui-Ping Rong; Wen-Qing He; Chun-Xia Zhang; Shi Li; Ru-Yu Su; Xiang Chang; Ji-Huan Qin; Yun-Bo Chen; Shao-Xiang Xian; Qi Wang
Journal:  Rejuvenation Res       Date:  2015-04       Impact factor: 4.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.